Study shows significant progress in HIV treatment initiation in the Asia-Pacific region

Published Date: 20 Mar 2025

In a study published in AIDS Research and Therapy, Ph.D. candidate Thinh Vu explores the temporal trends in the time from HIV diagnosis to the initiation of antiretroviral therapy (ART) across the Asia-Pacific region. This ...

Read Full News

Latest News

Congo Set to Receive 70,000 Ervebo Vaccines to Contain Ebola Outbreak, WHO Says

The Democratic Republic of Congo has been allocated 70,000 doses of Merck's Ervebo vaccine for Ebola, the World Health ⁠Organization said on Thursday, as the country...

Lenacapavir PrEP: No New HIV infections & High Satisfaction

Participants in the PURPOSE 1 trial particularly appreciated the convenience of not needing a daily pill and the confidence of feeling protected from HIV long-term.

Ebola Cases in Congo Exceed 5,000, Government Data Shows

The number of confirmed Ebola cases in the Democratic Republic ⁠of Congo now exceeds 5,000, government data showed late on Tuesday, as ⁠health officials warn that response...

Kids With Complex Conditions Face Higher Antibiotic Exposure

Children with complex chronic conditions have a higher likelihood of receiving antibiotic prescriptions than their healthy peers.

Doravirine Add-On Boosts Virologic Control in HIV Infection

Adding doravirine to an existing antiretroviral regimen helps people living with HIV regain virologic control, especially when background drugs remain active.

WHO Says Congo Ebola Outbreak Can Still Be Brought Under Control Within Three Months

A World Health Organization official said on Tuesday it was still possible to bring under control an ⁠Ebola outbreak that is outpacing containment efforts and has become the...

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Latest News

The Democratic Republic of Congo has been allocated 70,000 doses of Merck's Ervebo vaccine for Ebola, the World Health ⁠Organization said on Thursday, as the country...

Participants in the PURPOSE 1 trial particularly appreciated the convenience of not needing a daily pill and the confidence of feeling protected from HIV long-term.

The number of confirmed Ebola cases in the Democratic Republic ⁠of Congo now exceeds 5,000, government data showed late on Tuesday, as ⁠health officials warn that response...

Children with complex chronic conditions have a higher likelihood of receiving antibiotic prescriptions than their healthy peers.

Adding doravirine to an existing antiretroviral regimen helps people living with HIV regain virologic control, especially when background drugs remain active.

A World Health Organization official said on Tuesday it was still possible to bring under control an ⁠Ebola outbreak that is outpacing containment efforts and has become the...

News All Time

Congo Reports Ebola Death in New Province, Official Says

Democratic Republic of Congo health authorities have identified a person who has died from Ebola ⁠in a province not previously affected by the ongoing outbreak, an official...

Once-Weekly Oral ART Matches Daily ART for Viral Suppression

The potential arrival of once-weekly oral ART options could be particularly important for those who face challenges of stigma or adherence difficulties, advocate says.

UK Regulator Endorses Safety Of Childhood Vaccination

Britain's health regulator on Wednesday reaffirmed the safety of ⁠childhood vaccination and endorsed it as an effective and safe way ⁠to safeguard against serious infectious...

Vaccination in Pregnancy Embraced by Ob/Gyns

Long the primary purview of pediatricians, routine discussion and administration of vaccines is an increasing focus of obstetric clinicians.

Controlled Breathing May Help Cut Addiction Cravings

Controlled breathing interventions are associated with reduced craving in patients with substance use disorders compared with control interventions, new research shows.

Encephalitis Linked to Long-Term Dementia Risk

Survivors of encephalitis face elevated dementia risk years later, with the magnitude varying by age and etiology, a study shows.

Meningococcal B Vaccine May Cut Gonorrhea Risk in Teens

A multicomponent meningococcal B vaccine showed modest protection against gonorrhea in a high-burden population, a study shows.

Australia to Vaccinate Vulnerable Native Birds Against Bird Flu

Australia will soon begin vaccinating its vulnerable native birds against the deadly H5N1 bird ⁠flu as the virus spreads more widely after first being detected in the...

New Transmission From Animals Likely Caused Congo-Uganda Ebola Outbreak, Study Says

The ongoing Ebola outbreak in Democratic Republic of Congo concerns a previously unseen ⁠variant of the rare Bundibugyo species of the virus, indicating it stemmed from a...

HIV Care Disengagement Common in Missouri

A pattern of cycling in and out of care challenges the linear depiction of the HIV care continuum, with implications for retention strategies in priority jurisdictions.

HIV and Hepatitis C Screening at Appalachian Music Festival

A similar model of bringing testing into less engaged communities could potentially be implemented elsewhere with adequate funding, resources, and buy-in.

Roche Launches Two New Cyclospora Tests as US Outbreak Widens

Roche said on Thursday it launched two new tests to detect cyclospora, as ⁠U.S. cyclosporiasis cases climbed to record levels this year making the foodborne-illness outbreak...

Michigan Eases Lettuce Advice as State Health Department Says Cyclosporiasis Reports Decline

Michigan health officials on Thursday advised residents to resume eating lettuce and salad greens, citing a slowdown in new cyclosporiasis infections, after reporting...

US Will Nearly Double Financial Commitment to Ebola Response

The U.S. State Department on Wednesday nearly doubled its financial commitment to the Ebola response in eastern Democratic Republic of Congo, announcing ⁠plans to provide an...

US FDA Approves First MRNA Flu Shot From Moderna

The U.S. Food and Drug Administration has approved Moderna's flu vaccine for people aged 50 and older, the company said on Wednesday, marking the first approval ⁠of a...

Baseline Steroids Fail to Benefit Bronchiectasis Patients

Observational data show an association between baseline inhaled corticosteroid use and poor outcomes after a year.

Recommended News For You

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

Sickle Cell Disease Drug Pulled From Global Markets

After two years, a significant left nasal obstruction was finally diagnosed.

Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.

enhancing survivors of brain tumors' quality of life.

Recommended Articles For You

Strategic Standards in Hematology for Specialists 

Metabolic Vulnerabilities in Solid Tumor Progression 

Revolutionizing Cancer Treatment: Harnessing the Power of AI in Histopathology 

Understanding Melanoma: From Diagnosis to Healing and Excision in Denver 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Q&A: When will individuals be able to receive customized cancer vaccines?

2.

Canadian Group Calls for Earlier Colorectal Cancer Screening

3.

Children living near oil and gas wells face higher risk of rare leukemia, studies show

4.

Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.

5.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

1.

Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer

2.

Clinical Pharmacology of Megakaryocyte Maturation-Targeted Therapeutics

3.

The Benefits and Side Effects of Bortezomib in the Fight Against Cancer 

4.

Personalized Tumor Ecological Landscapes in Oncology

5.

Unmasking the Subtle Symptoms of Colon Cancer

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

3.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

4.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

5.

Immunotherapy: A New Era in Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot